PerceptiMed appoints Frank Starn CEO

July 2019  |  PerceptiMed Staff

MOUNTAIN VIEW, Calif.  July 15, 2019 — The board of directors of PerceptiMed announced Tuesday that Frank Starn has been appointed chief executive officer.

Frank StarnCiting the success the company is having with its scripClip pick-to-light will call system, Dr. Rod Markin, PerceptiMed chairman, said the time had come for the company to bring on a CEO with a proven track record of success and with the industry knowledge and relationships to accelerate the company’s growth.

Starn served for 12 years in senior management positions with McKesson Corp. Starn was most recently senior vice president and COO of McKesson’s U.S. Pharmaceuticals Distribution Group. Prior to those roles, he served as president of Global Sourcing as well as senior vice president and CFO of the U.S. Pharmaceuticals Group. Prior to McKesson, Starn served as a senior executive at Whirlpool Corporation in the US, China and Europe.

Starn will assume his duties immediately. Bob Curry the outgoing CEO – who has 32 years of health care venture capital investing experience – will continue to serve on the board. Markin said PerceptiMed is excited to have Starn join the Company and looks forward to PerceptiMed’s continued rapid growth.